Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Safety guide Ipamorelin Side Effects & Safety Frequency, contraindications, and who is a good candidate Recent Ipamorelin Research [PubMed] Ipamorelin, the first selective growth hormone secretagogue (Eur J Endocrinol, 1998) Foundational paper by the Novo Nordisk research group characterizing Ipamorelin as the first GH secretagogue to demonstrate full GH-releasing potency with no significant effect on cortisol, prolactin, or ACTH at therapeutic doses
Electrophysiological and c-Fos mapping studies in rodent models have demonstrated that amylin receptor activation in these regions inhibits gastric emptying, reduces meal size, and activates downstream satiety circuits projecting to the hypothalamic arcuate nucleus (Lutz et al., Physiology & Behavior, 2010)
It covers effects, studies, safety notes, and legal status
Fabrini R, Bocedi A, Del Grosso E, Morici L, Federici G, Palleschi A et al
De Luca P, Cassandro C, Ralli M, et al
US$ 20.69
US$ 29.23
US$ 21.65
US$ 24.89
US$ 27.38
